Clinical Trials Browser

Phase NA × apalutamide × Clear all

NCT05649943 2025-09-03

APPROACH

Phase NA Recruiting

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT04997252 2024-03-18

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

Phase NA Unknown

High-Risk and Oligometastatic Prostate Cancer

NCT05740488 2024-03-15

Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases

Phase NA Unknown

Prostate Cancer With ≤10 Bone Metastases